{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,11,7]],"date-time":"2025-11-07T19:12:21Z","timestamp":1762542741565},"reference-count":30,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"3","license":[{"start":{"date-parts":[[2018,3,1]],"date-time":"2018-03-01T00:00:00Z","timestamp":1519862400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"content-domain":{"domain":["jurology.com","clinicalkey.jp","clinicalkey.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.fr","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Urology"],"published-print":{"date-parts":[[2018,3]]},"DOI":"10.1016\/j.juro.2017.09.033","type":"journal-article","created":{"date-parts":[[2017,9,12]],"date-time":"2017-09-12T17:01:21Z","timestamp":1505235681000},"page":"726-733","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":14,"title":["Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using\n            <sup>11<\/sup>\n            C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging"],"prefix":"10.1097","volume":"199","author":[{"given":"Avinash","family":"Nehra","sequence":"first","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"William P.","family":"Parker","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Rimki","family":"Haloi","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sean S.","family":"Park","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Lance A.","family":"Mynderse","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Val J.","family":"Lowe","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Brian J.","family":"Davis","sequence":"additional","affiliation":[{"name":"Department of Radiation Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"J. Fernando","family":"Quevedo","sequence":"additional","affiliation":[{"name":"Department of Medical Oncology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Geoffrey B.","family":"Johnson","sequence":"additional","affiliation":[{"name":"Department of Radiology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Eugene D.","family":"Kwon","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"R. Jeffrey","family":"Karnes","sequence":"additional","affiliation":[{"name":"Department of Urology, Mayo Clinic, Rochester, Minnesota"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"10.1016\/j.juro.2017.09.033_bib1","unstructured":"National Cancer Institute Surveillance, Epidemiology, and End Results Program: Cancer Stat Facts: Prostate Cancer. Available at https:\/\/seer.cancer.gov\/statfacts\/html\/prost.html. Accessed August 30, 2017."},{"key":"10.1016\/j.juro.2017.09.033_bib2","doi-asserted-by":"crossref","first-page":"1175","DOI":"10.1016\/j.eururo.2007.01.015","article-title":"Natural history of biochemical recurrence after radical prostatectomy: risk assessment for secondary therapy","volume":"51","author":"Simmons","year":"2007","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib3","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1002\/cncr.23293","article-title":"A nomogram predicting long-term biochemical recurrence after radical prostatectomy","volume":"112","author":"Suardi","year":"2008","journal-title":"Cancer"},{"key":"10.1016\/j.juro.2017.09.033_bib4","doi-asserted-by":"crossref","first-page":"893","DOI":"10.1016\/j.eururo.2011.02.026","article-title":"Long-term risk of clinical progression after biochemical recurrence following radical prostatectomy: the impact of time from surgery to recurrence","volume":"59","author":"Boorjian","year":"2011","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib5","doi-asserted-by":"crossref","first-page":"555","DOI":"10.1016\/S0094-0143(05)70163-4","article-title":"Long-term biochemical disease-free and cancer-specific survival following anatomic radical retropubic prostatectomy. The 15-year Johns Hopkins experience","volume":"28","author":"Han","year":"2001","journal-title":"Urol Clin North Am"},{"key":"10.1016\/j.juro.2017.09.033_bib6","doi-asserted-by":"crossref","first-page":"2018","DOI":"10.1016\/S0140-6736(12)61253-7","article-title":"Postoperative radiotherapy after radical prostatectomy for high-risk prostate cancer: long-term results of a randomised controlled trial (EORTC trial 22911)","volume":"380","author":"Bolla","year":"2012","journal-title":"Lancet"},{"key":"10.1016\/j.juro.2017.09.033_bib7","doi-asserted-by":"crossref","first-page":"2924","DOI":"10.1200\/JCO.2008.18.9563","article-title":"Phase III postoperative adjuvant radiotherapy after radical prostatectomy compared with radical prostatectomy alone in pT3 prostate cancer with postoperative undetectable prostate-specific antigen: ARO 96-02\/AUO AP 09\/95","volume":"27","author":"Wiegel","year":"2009","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib8","doi-asserted-by":"crossref","first-page":"2035","DOI":"10.1200\/JCO.2006.08.9607","article-title":"Predicting the outcome of salvage radiation therapy for recurrent prostate cancer after radical prostatectomy","volume":"20","author":"Stephenson","year":"2007","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib9","doi-asserted-by":"crossref","first-page":"2040","DOI":"10.1200\/JCO.2010.32.2776","article-title":"Adjuvant androgen deprivation for high-risk prostate cancer after radical prostatectomy: SWOG S9921 study","volume":"29","author":"Dorff","year":"2011","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.1016\/S1470-2045(16)00111-X","article-title":"Salvage radiotherapy with or without short-term hormone therapy for rising prostate-specific antigen concentration after radical prostatectomy (GETUG-AFU 16): a randomised, multicentre, open-label phase 3 trial","volume":"17","author":"Carrie","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib11","doi-asserted-by":"crossref","first-page":"417","DOI":"10.1056\/NEJMoa1607529","article-title":"Radiation with or without antiandrogen therapy in recurrent prostate cancer","volume":"2","author":"Shipley","year":"2017","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2017.09.033_bib12","doi-asserted-by":"crossref","first-page":"727","DOI":"10.1016\/S1470-2045(16)00107-8","article-title":"Timing of androgen-deprivation therapy in patients with prostate cancer with a rising PSA (TROG 03.06 and VCOG PR 01-03 [TOAD]): a randomised, multicentre, non-blinded, phase 3 trial","volume":"17","author":"Duchense","year":"2016","journal-title":"Lancet Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib13","doi-asserted-by":"crossref","first-page":"607","DOI":"10.1016\/S0090-4295(02)02411-1","article-title":"Limited value of bone scintigraphy and computer tomography in assessing biochemical failure after radical prostatectomy","volume":"61","author":"Kane","year":"2003","journal-title":"Urology"},{"key":"10.1016\/j.juro.2017.09.033_bib14","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1111\/j.1464-410X.2004.04927.x","article-title":"Radionuclide bone scintigraphy in patients with biochemical recurrence after radical prostatectomy: when is it indicated?","volume":"94","author":"Gomez","year":"2004","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.09.033_bib15","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00330-008-1174-8","article-title":"Endorectal magnetic resonance imaging at 1.5 Tesla to assess local recurrence following radical prostatectomy using T2-weighted and contrast-enhanced imaging","volume":"19","author":"Cirillo","year":"2009","journal-title":"Eur Radiol"},{"key":"10.1016\/j.juro.2017.09.033_bib16","doi-asserted-by":"crossref","first-page":"1971","DOI":"10.1007\/s00259-016-3428-z","article-title":"11C-choline PET\/CT for restaging prostate cancer. Results from 4,426 scans in a single-centre patient series","volume":"43","author":"Graziani","year":"2016","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.juro.2017.09.033_bib17","doi-asserted-by":"crossref","first-page":"19","DOI":"10.6004\/jnccn.2016.0004","article-title":"Prostate cancer, version 1.2016","volume":"14","author":"Mohler","year":"2016","journal-title":"J Natl Compr Canc Netw"},{"key":"10.1016\/j.juro.2017.09.033_bib18","doi-asserted-by":"crossref","first-page":"467","DOI":"10.1016\/j.eururo.2013.11.002","article-title":"EAU guidelines on prostate cancer. Part II: treatment of advanced, relapsing, and castration-resistant prostate cancer","volume":"65","author":"Heidenreich","year":"2014","journal-title":"Eur Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib19","doi-asserted-by":"crossref","first-page":"223","DOI":"10.2967\/jnumed.113.123018","article-title":"Detection of recurrent prostate cancer after radical prostatectomy: comparison of 11C-choline PET\/CT with pelvic multiparametric MR imaging with endorectal coil","volume":"55","author":"Kitajima","year":"2014","journal-title":"J Nucl Med"},{"key":"10.1016\/j.juro.2017.09.033_bib20","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1016\/j.juro.2012.10.069","article-title":"Operational characteristics of 11C-choline positron emission tomography\/computerized tomography for prostate cancer with biochemical recurrence after initial treatment","volume":"189","author":"Mitchell","year":"2013","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib21","doi-asserted-by":"crossref","first-page":"526","DOI":"10.1016\/j.ijrobp.2016.11.014","article-title":"Patterns of recurrence after postprostatectomy fossa radiation therapy identified by C-11 choline positron emission tomography\/computer tomography","volume":"97","author":"Parker","year":"2017","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"10.1016\/j.juro.2017.09.033_bib22","doi-asserted-by":"crossref","first-page":"129","DOI":"10.1016\/j.juro.2016.07.073","article-title":"Contemporary mapping of post-prostatectomy prostate cancer relapse with 11C-choline positron emission tomography and multiparametric magnetic resonance imaging","volume":"197","author":"Sobol","year":"2017","journal-title":"J Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib23","doi-asserted-by":"crossref","first-page":"406","DOI":"10.1111\/bju.13510","article-title":"Toxicity and efficacy of salvage carbon 11-choline positron emission tomography\/computer tomography-guided radiation therapy in patients with lymph node recurrence of prostate cancer","volume":"119","author":"Fodor","year":"2017","journal-title":"BJU Int"},{"key":"10.1016\/j.juro.2017.09.033_bib24","doi-asserted-by":"crossref","first-page":"3973","DOI":"10.1200\/JCO.2005.04.0756","article-title":"Defining biochemical recurrence of prostate cancer after radical prostatectomy: a proposal for a standardized definition","volume":"24","author":"Stephenson","year":"2006","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib25","doi-asserted-by":"crossref","first-page":"1471","DOI":"10.1245\/s10434-010-0985-4","article-title":"The American Joint Committee on Cancer: the 7th edition of the AJCC cancer staging manual and the future of TNM","volume":"17","author":"Edge","year":"2010","journal-title":"Ann Surg Oncol"},{"key":"10.1016\/j.juro.2017.09.033_bib26","series-title":"Adjuvant and Salvage Radiotherapy after Prostatectomy: ASTRO\/AUA Guideline","author":"Thompson","year":"2013"},{"key":"10.1016\/j.juro.2017.09.033_bib27","doi-asserted-by":"crossref","first-page":"1611","DOI":"10.1007\/s00345-016-1823-5","article-title":"Use of androgen deprivation therapy as salvage treatment after primary therapy for clinically localized prostate cancer","volume":"34","author":"Fu","year":"2016","journal-title":"World J Urol"},{"key":"10.1016\/j.juro.2017.09.033_bib28","doi-asserted-by":"crossref","first-page":"737","DOI":"10.1056\/NEJMoa1503747","article-title":"Chemohormonal therapy in metastatic hormone-sensitive prostate cancer","volume":"373","author":"Sweeney","year":"2015","journal-title":"N Engl J Med"},{"key":"10.1016\/j.juro.2017.09.033_bib29","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1007\/s00259-009-1253-3","article-title":"Predictive factors of [(11)C] choline PETCT in patients with biochemical failure after radical prostatectomy","volume":"37","author":"Giovacchini","year":"2010","journal-title":"Eur J Nucl Med Mol Imaging"},{"key":"10.1016\/j.juro.2017.09.033_bib30","doi-asserted-by":"crossref","first-page":"852","DOI":"10.1016\/j.eururo.2014.09.004","article-title":"Metastasis-directed therapy of regional and distant recurrences after curative treatment of prostate cancer: a systematic review of the literature","volume":"67","author":"Ost","year":"2015","journal-title":"Eur Urol"}],"container-title":["Journal of Urology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717774976?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0022534717774976?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/www.jurology.com\/doi\/pdf\/10.1016\/j.juro.2017.09.033","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,4,29]],"date-time":"2022-04-29T05:07:32Z","timestamp":1651208852000},"score":1,"resource":{"primary":{"URL":"http:\/\/www.jurology.com\/doi\/10.1016\/j.juro.2017.09.033"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,3]]},"references-count":30,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2018,3]]}},"alternative-id":["10.1016\/j.juro.2017.09.033"],"URL":"https:\/\/doi.org\/10.1016\/j.juro.2017.09.033","relation":{},"ISSN":["0022-5347","1527-3792"],"issn-type":[{"value":"0022-5347","type":"print"},{"value":"1527-3792","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Identification of Recurrence Sites Following Post-Prostatectomy Treatment for Prostate Cancer Using 11C-Choline Positron Emission Tomography and Multiparametric Pelvic Magnetic Resonance Imaging","name":"articletitle","label":"Article Title"},{"value":"The Journal of Urology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.juro.2017.09.033","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 by AMERICAN UROLOGICAL ASSOCIATION EDUCATION AND RESEARCH, INC.","name":"copyright","label":"Copyright"}]}}